Navigation Links
ViroPharma to Present at Several Upcoming Healthcare Conferences
Date:9/3/2009

EXTON, Pa., Sept. 3 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that the company will be presenting in four upcoming healthcare investment conferences during the month of September.

Charles Rowland, vice president and chief financial officer of ViroPharma, will present at the Rodman & Renshaw 11th Annual Global Healthcare Conference at 11:15 A.M. ET on Thursday, September 10, 2009. The conference is being held at the New York Palace Hotel.

Vincent Milano, president and chief executive officer of ViroPharma, will present at the Thomas Weisel Partners 2009 Global Healthcare Conference at 8:00 A.M. ET on Thursday, September 10, 2009. The conference is being held at the Four Seasons Hotel in Boston.

William Roberts, vice president, corporate communications will present at the BioCentury Newsmakers in the Biotech Industry Conference at 3:30 P.M. ET on Wednesday, September 16, 2009. The conference is being held at the Millennium Broadway Hotel in New York City.

Mr. Milano will also present at the ThinkEquity 6th Annual Growth Conference at 5:15 P.M. ET (2:15 P.M. PT) on Wednesday, September 16, 2009. The conference is being held at the St. Regis Hotel in San Francisco.

ViroPharma's presentations will be webcast live for investors through www.viropharma.com and available for a period of 14 days following the conferences.

About ViroPharma Incorporated

ViroPharma Incorporated is a biopharmaceutical company dedicated to the development and commercialization of products that address serious diseases treated by physician specialists and in hospital settings. ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of ant
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. ViroPharma Receives Complete Response Letter for Cinryze(TM) Supplemental Biologics License Application for Acute Treatment of Hereditary Angioedema
2. ViroPharma to Present at Two June Healthcare Conferences
3. ViroPharma Incorporated Honored by the National Organization for Rare Disorders
4. ViroPharma Incorporated Reports First Quarter 2009 Financial Results
5. ViroPharma to Release 2009 First Quarter Financial Results on April 29, 2009
6. ViroPharma Improves Financial Position Through Repurchase of $45 Million Principal Amount of Senior Convertible Notes
7. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results
8. ViroPharma to Present at Three November Healthcare Conferences
9. ViroPharma Enhances Leadership to Support Global Growth and Expanding Business
10. ViroPharma to Release 2008 Third Quarter Financial Results on October 29, 2008
11. ViroPharma to Present at Three October Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... rise the U.S. in November, even as the overall unemployment rate ... in the pharmaceutical industry. , ... (Vocus) December 17, ... job losses - which is to say, there were no ... area was related to the Pfizer acquisition of Wyeth. Meanwhile, healthcare ...
(Date:12/16/2009)... as fact among historians, journalists and politicians, and has ... of the U.S. Congress: British forces used chemical weapons ... But that claim has never been fully squared with ... at Colgate University. According to Douglas,s research, forthcoming in ... History , no such incident ever occurred. , ...
(Date:12/16/2009)... after the Nanyang Technological University (NTU) signed the ... Center for Scientific Research (CNRS) and the Thales ... research laboratory, the three parties are meeting again ... (CINTRA) Laboratory at NTU. , Located at ... to harness the latest in science and technology ...
(Date:12/16/2009)... LAS VEGAS, Dec. 16 Cord Blood ... cord blood stem cell preservation company ( http://www.cordblood-america.com ... potential of stem cells, a biological insurance policy, ... it has reduced its debt by a total ... quarter of 2009 and total debt eliminated for ...
Breaking Biology Technology:The MedZilla Report for November 2009 - Healthcare Employment Up, And No Major Bad News for Pharma, Either 2The MedZilla Report for November 2009 - Healthcare Employment Up, And No Major Bad News for Pharma, Either 3Despite claims, UK did not gas Iraqis in the 1920s, new research finds 2Despite claims, UK did not gas Iraqis in the 1920s, new research finds 3Despite claims, UK did not gas Iraqis in the 1920s, new research finds 4New Singapore-French nanotech lab opens at NTU 2New Singapore-French nanotech lab opens at NTU 3Cord Blood America Says 2009 Debt Reduction Tops $10 Million 2Cord Blood America Says 2009 Debt Reduction Tops $10 Million 3
... technology to generate antibodies against ... novel research targets provided by Sigma-Aldrich, MUNICH, ... SIAL ) and MorphoSys AG (Frankfurt Stock,Exchange: ... agreement to design, produce and distribute unique,recombinant research ...
... SyntheMed, Inc. (OTC,Bulletin Board: SYMD), a biomaterials company ... drug delivery products and,other surgical implants, announced today ... at the Canaccord Adams, Small-Cap Orthopedics,conference on March ... Francisco, CA. Mr.,Hickey will present a company overview., ...
... Inc.,(Nasdaq: RDYN ) today announced its financial results for ... Replidyne reported a net loss of $16.9 million for the ... basic and diluted common share,of $0.63 per share, compared to ... diluted common share, for the quarter ended December 31, 2006.,For ...
Other Biology Technology:Sigma-Aldrich and MorphoSys Enter Into a Collaboration and Licensing Agreement for Recombinant Research Antibodies 2Sigma-Aldrich and MorphoSys Enter Into a Collaboration and Licensing Agreement for Recombinant Research Antibodies 3Replidyne Announces 2007 Fourth Quarter and Full Year Results 2Replidyne Announces 2007 Fourth Quarter and Full Year Results 3Replidyne Announces 2007 Fourth Quarter and Full Year Results 4Replidyne Announces 2007 Fourth Quarter and Full Year Results 5Replidyne Announces 2007 Fourth Quarter and Full Year Results 6Replidyne Announces 2007 Fourth Quarter and Full Year Results 7
(Date:12/16/2009)... winners of its student travel award to attend the ... Center in San Francisco, California, February 20-24, 2010. The ... scientific merit, with priority given to those who will ... receives a travel grant and will be recognized at ... recipients of the Student Travel Award are: , , Katherine ...
(Date:12/16/2009)... vital source of financial and technical assistance to developing ... not appear to be connected to space technology, but ... are intrinsically linked. , Global climate change is also ... development in the poorest countries and communities, which will ... have led to a growing demand for information about ...
(Date:12/16/2009)... pesticides in rivers and basins may limit the ... addition to the widespread deterioration of salmon habitats, ... pesticides may further inhibit the recovery of threatened ... currently underway to restore Pacific salmon habitats in ... Baldwin of the National Oceanic and Atmospheric Administration ...
Breaking Biology News(10 mins):Biophysical Society announces winners of 2010 Student Travel Awards 2Biophysical Society announces winners of 2010 Student Travel Awards 3Biophysical Society announces winners of 2010 Student Travel Awards 4ESA and World Bank move toward closer collaboration 2ESA and World Bank move toward closer collaboration 3ESA and World Bank move toward closer collaboration 4Even at sublethal levels, pesticides may slow the recovery of wild salmon populations 2MRI May Help Find Deep Endometriosis 50971 1MRI May Help Find Deep Endometriosis 50971 2Pharmacyclics Sets Record Date for Rights Offering 50966 1Pharmacyclics Sets Record Date for Rights Offering 50966 2Pharmacyclics Sets Record Date for Rights Offering 50966 3New national adolescent weight control registry will recognize successful teen weight loss efforts 50961 1New national adolescent weight control registry will recognize successful teen weight loss efforts 50961 2
... The National Institutes of Health has awarded one of ... to a team based at the University of Chicago ... in 2006, form the core of an NIH effort ... will "transform how clinical and translational research is conducted," ...
... smell pleasant and another odious? Is there something in the ... we will perceive its smell? Scientists at the Weizmann Institute ... now discovered that there is, indeed, such a link, and ... whether we will find its smell heavenly or malodorous. ...
... the Georgia Institute of Technology have developed a miniature ... silicon disk to measure pollutants present in aqueous or ... surface coatings could be used during field-testing to rapidly ... this new sensor allows water and air samples to ...
Other Biology News:NIH awards nearly $23M to University of Chicago for translational research 2NIH awards nearly $23M to University of Chicago for translational research 3NIH awards nearly $23M to University of Chicago for translational research 4Sweet smell 2New microsensor measures volatile organic compounds in water and air on-site 2New microsensor measures volatile organic compounds in water and air on-site 3
... FLISP Assay with FAM-Labeled Substrate (green ... Accurately measure serine protease activation • ... B-Bridge's FLISP Kits utilize cell-permeable, fluorescently ... to measure chymotrypsin-like activity in whole ...
... Chemicons protein array systems, known ... are particularly useful compared with current ... protein expression, Chemicons systems present a ... levels because they only detect secreted ...
... The DNA Engine instrument is ... Unprecedented thermal uniformity and ... and block-to-block. This rugged ... cycler, it's a platform for new ...
... Species Tissue Array (MSTA) slides were designed to ... tissues from multiple species. Tissue slices from ... slide which can then be treated as a ... in situ hybridization. This format ...
Biology Products: